Overview

• Cellulose producer's Q4 net sales of $417 mln beat analyst expectations

• Q4 loss from continuing operations was $21 mln

• Q4 adjusted EBITDA from continuing operations fell to $46 mln

Outlook

• Company aims to deliver positive free cash flow in 2026

• Rayonier Advanced Materials plans to reduce CapEx in 2026

• Company expects early 2026 volumes to be pressured as customers adjust inventory

Result Drivers

• CELLULOSE SPECIALTIES - Net sales increased due to a 7% rise in average sales price, despite a 4% decrease in sales volumes

• BIOMATERIALS GROWTH - Segment net sales rose 25% due to higher lignosulfonates and bioethanol sales

• CELLULOSE COMMODITIES - Sales increased by 7% due to higher sales price and volumes, but offset by higher logistics and energy costs

Company press release: ID:nBwrWfzYa

Key Details

Analyst Coverage

• The one available analyst rating on the shares is "buy"

• The average consensus recommendation for the specialty chemicals peer group is "buy"

• Wall Street's median 12-month price target for Rayonier Advanced Materials Inc is $9.00, about 5.9% below its March 2 closing price of $9.56

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.